Home » Topics » Regulatory

Regulatory
RSS

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

FDA clears generic version of SKB's Compazine

May 6, 1997

Alpharma's Oral Acyclovir Suspension launched in the U.S.

May 2, 1997

Nippon Kayaku reports neuritogenic effects for known compound

May 2, 1997

ESI Lederle launches generic acyclovir

April 29, 1997

FDA approves new labeling for Bristol-Myers Squibb's Pravachol

April 29, 1997

Mylan Laboratories's Acyclovir receives FDA approval

April 25, 1997

Final FDA approval for Faulding's acyclovir injection

April 24, 1997

IVAX presents promising preclinical results with Elmiron

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...